The significant difference in nuclear OCT4 and nucleocytoplasmic NANOG expressions between ccRCC, compared with the chRCC and pRCC tumor samples, indicates that OCT4 and NANOG may act as a diagnostic markers to distinguish ccRCC from chRCC and pRCC subtypes. This evidence concerns the gene NANOG and nonpapillary renal cell carcinoma.